"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT02560584","A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting",,"Completed","Has Results","Bladder Cancer","Drug: Hexaminolevulinate hydrochloride|Device: KARL STORZ D-Light C PDD Flexible Videoscope System","Proportion of Patients With Histologically Confirmed Malignancy Where Malignancy is Only Detected With Blue Light Cystoscopy With Cysview and Not White Light Cystoscopy|Proportion of Patients With Adverse Events Considered Causally Related to Cysview and/or Blue Light in the Surveillance Examination Compared With the OR Examination|Proportion of Patients With One or More Carcinoma in Situ (CIS) Lesions Detected With Blue Light Cystoscopy With Cysview and None With White Light Cystoscopy","Photocure|KARL STORZ Endoscopy-America, Inc.","All","18 Years and older   (Adult, Older Adult)","Phase 3","304","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","PC B308/13","October 1, 2015","April 5, 2017","April 5, 2017","September 25, 2015","July 2, 2018","July 2, 2018","USC Norris Comprehensive Cancer Center, Los Angeles, California, United States|University of Chicago Medical Center, Chicago, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|Johns Hopkins University, Baltimore, Maryland, United States|University of Minnesota, Minneapolis, Minnesota, United States|Montefiore Medical Center, Bronx, New York, United States|NYU Langone Urology Associates, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|University of North Carolina, Department of Urology, Chapel Hill, North Carolina, United States|Ohio State University The James Cancer Hospital, Columbus, Ohio, United States|University of Oklahoma-Stephenson Cancer Center, Oklahoma City, Oklahoma, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|UT Southwestern Medical Center, Dallas, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Michael E. DeBakey VA Medical Center, Houston, Texas, United States|University of Wisconsin, Madison, Wisconsin, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/84/NCT02560584/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02560584"
2,"NCT00602979","Comparison Study in Adult Surgical Patients of 5 Airway Devices",,"Completed","Has Results","Laryngoscopy|Intubation","Device: Macintosh laryngoscope|Device: Airtraq® Optical Laryngoscope|Device: Storz DCI Video Laryngoscope®|Device: GlideScope® Video Laryngoscope|Device: McGRATH® Video Laryngoscope","Percentage Distribution of Cook's Modification of Cormack-Lehane's Grading System. Each Study Subject Will Receive a Grade of 1, 2A, 2B, 3A, 3B, or 4 in the Cormack-Lehane Grading System.","Weill Medical College of Cornell University|King Systems Corporation|KARL STORZ Endoscopy-America, Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","240","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","0710009433","April 2008","September 2009","July 2011","January 28, 2008","May 19, 2017","May 19, 2017",,,"https://ClinicalTrials.gov/show/NCT00602979"
